TDF drugs are used to treat HIV/AIDS. The drug clinically known as tenofovir disoproxil fumarate (or TDF) was approved as an oral HIV treatment in 2001. It is an antiretroviral, which basically disrupts the progression of the HIV virus at the cellular level. The drugmaker, Gilead Sciences, markets TDF in combination with other drugs under the popular brand name, Truvada, as well as other brand names, such as Atripla, Complera, Stribild, Symfi-Lo, Cimduo and Viread. Unfortunately, studies have shown that taking TDF drugs can cause severe kidney and bone injuries.
The drugmaker, Gilead Sciences, has been the subject of numerous lawsuits, including one filed by the AIDS Healthcare Foundation. These lawsuits essentially allege that Gilead knew that TDF drugs had to be given in high doses to be effective, which meant it could damage the kidneys and bones. Yet the company failed to adequately disclose those dangers in the medicine’s label.
Moreover, Gilead is alleged to have developed a much safer HIV treatment compound, tenofovir alafemanide fumarate (or TAF). However, it is alleged that Gilead purposefully delayed the introduction of the safer TAF drugs, despite Gilead’s knowledge of the injuries being caused by the TDF drugs, in order to reap extended profits from Gilead’s drug patents on the TDF drugs (at the height of usage, Gilead’s TDF drugs were earning over $10 billion in annual sales). Complaints go on to assert that, after Gilead purposefully delayed the development of its TAF drugs, Gilead did eventually market TAF in combination with other drugs, under the brand names Genyova, Odefsey, Descovy and Biktarvy. But, by that time, there had already been thousands of reports of severe kidney and bone injuries from TDF drug therapy.
Those injuries include, but are not limited to:
If you or a loved one has taken a TDF drug (such as Truvada, Atripla, Complera, Stribild, or Viread) and experienced serious kidney or bone injuries, you may be entitled to compensation.
It is strongly recommended that you seek counsel experienced in TDF drug claims and injuries. Stark & Stark’s TDF drug claims attorneys are actively seeking TDF drug settlements and filing TDF drug lawsuits against the makers of TDF drug, on behalf of patients injured by this potentially defective drug. Contact us at no cost to you.
Attorneys across the nation are currently filing individual and class action lawsuits against the manufacturer of TDF drugs, based on claims that the manufacturer should have warned patients – and their doctors – of the known potential side effects of TDF drugs. These lawsuits further allege that the manufacturer of TDF drugs should have discontinued those drugs, in favor of the much safer alternative TAF drugs. It is expected that most or all of these claims will eventually be consolidated in a Multi-District Litigation (MDL), which centralizes pretrial activities for multiple cases to save time, court costs, and attorneys’ fees.
If you or a loved one has taken a TDF drug (such as Truvada, Atripla, Complera, Stribild, Symfi-Lo, Cimduo or Viread) and experienced serious kidney or bone injuries, it is strongly recommended that you seek legal counsel with attorneys who are experienced in TDF drug claims and injuries.
Stark & Stark attorneys are actively pursuing TDF drug lawsuits and settlements against the drugmaker Gilead on behalf of patients injured by this potentially dangerous drug. If you have a TDF drug claim, or you are uncertain and have questions about injuries that you may have suffered because of TDF drug use, the TDF drug claims attorneys at Stark & Stark can help.
Stark & Stark is committed to holding drug manufacturers liable when their products improperly endanger the public. Our TDF drug claims lawyers are experienced in mass torts MDL litigation cases and in negotiating with medical device and pharmaceutical settlement representatives. We are not a marketing group. Stark & Stark is a law firm comprised of experienced trial lawyers.
Stark & Stark is a national law firm pursuing thousands of cases throughout the country. We have been in business for over 80 years and have over 100 attorneys in offices located throughout New Jersey, Pennsylvania and New York. Let us help you.
Stark & Stark Attorneys Recognized as New Jersey “Super Lawyers” and “Rising Stars” in 2026
Stark & Stark is pleased to announce that 15 of its attorneys have been selected for inclusion in the list of 2026 New Jersey Super Lawyers,...Bruce Stern, Esq. Secures $1,000,000 Settlement in Motor Vehicle Collision Case
Bruce Stern, Esq. recently secured a $1,000,000 settlement in a motor vehicle collision case.* “This case highlights how quickly things can go...Deborah Dunn, Esq. Elected to Board of Directors for Angel Flight East
Stark & Stark is pleased to announce that Deborah Dunn, Esq., Shareholder and Civil Trial Attorney, has been elected to the Board of Directors...Michael Jordan, Esq. Joins the Board of the Lawrence Township Community Foundation
It is our pleasure to announce that Michael Jordan, Esq. has joined the board of the Lawrence Township Community Foundation, an organization...Joseph Lemkin, Esq. Named to ROI-NJ Influencers: Power List 2026 – Law
Stark & Stark is proud to share that Joseph Lemkin, Esq., Shareholder, has been named to the 2026 Influencers: Power List in the Law category...Joseph Cullen, Esq. and Nicole Durso, Esq. Secure $2,000,000 Settlement in Personal Injury Matter
Joseph Cullen, Esq. and Nicole Durso, Esq. recently secured a $2,000,000 settlement in a personal injury matter involving a pedestrian who was struck...James Creegan, Esq. Appointed to Board of The 200 Club of Mercer County
It is our pleasure to announce that James Creegan, Esq. has been appointed to the Board of Directors of The 200 Club of Mercer County, an...